Какова цена за Roche Holding AG (RO)

Цена за Roche Holding AG (RO) Это $481.73

Какова рыночная капитализация для Roche Holding AG (RO)

Рыночная капитализация для Roche Holding AG (RO) Это $377.65B

Прибыль Roche Holding AG (RO)

Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.

Год	Прибыль	Изменить
Недостаточно данных для указанных дат.

Год

Прибыль

Изменить

Недостаточно данных для указанных дат.

Компания	Прибыль	Разница в прибыли	Страна
Eli Lilly and Company LLY.US	$33.59B	57.07%	US
Johnson & Johnson JNJ.US	$25.20B	17.80%	US
AbbVie Inc. ABBV.US	$8.70B	-59.33%	US
Merck & Co., Inc. MRK.US	$5.95B	-72.19%	US
Novartis AG NOVN.SW	$16.38B	-23.42%	CH

Компания

Прибыль

Разница в прибыли

Страна